Effects of a Late Phase Exercise Program Following Total Hip Arthroplasty
NCT ID: NCT00896259
Last Updated: 2012-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
47 participants
OBSERVATIONAL
2009-03-31
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To examine the effects of the late phase education session and home-based exercise program in restoring hip muscle strength, gait and function
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
THA control
those with THA not participating in exercise and education program
No interventions assigned to this group
THA exercise
those with THA and participating in exercise and education program
home based exercise and education program
Individual assessment with physiotherapist with educational information, exercise instruction and prescription provided. Instructed to perform home exercises and walking for 12 weeks. Will be individually tailored to participants, bi-monthly phone calls will be used to monitor and facilitate exercise and walking progression .
healthy control
Healthy control, people with no lower limb gait abnormalities
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
home based exercise and education program
Individual assessment with physiotherapist with educational information, exercise instruction and prescription provided. Instructed to perform home exercises and walking for 12 weeks. Will be individually tailored to participants, bi-monthly phone calls will be used to monitor and facilitate exercise and walking progression .
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 8-12 weeks post THA
* over the age of 18
* able to walk 15m without a walking aid
* able to participate in an exercise program without physical assistance
* available for follow up as per the study protocol
* able to read and understand English and follow verbal and visual instructions
Exclusion Criteria
* have central or peripheral nervous system deficits
* have an underlying terminal disease (cancer)
* have suspicion of infection following joint replacement
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Orthopaedic Foundation
OTHER
Nova Scotia Health Authority
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kim Parker
Rehabilitation Engineer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ann Read, BScPT, MSc
Role: PRINCIPAL_INVESTIGATOR
CDHA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Orthopedic Clinic, QEII Health Sciences Centre, CDHA
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDHA-RS/2007-057
Identifier Type: -
Identifier Source: org_study_id